Medicine
Fycompa 2 mg tablet
Fycompa 2 mg tablet is a prescription medicine containing Perampanel for oral use, marketed by Catalyst Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Tablets: store at 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Perampanel
- Brand
- Fycompa
- Strength
- 2 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets and 1 more
- Marketing authorisation holder
- Catalyst Pharmaceuticals
- Manufacturers
- Catalyst PharmaceuticalsEisai
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Tablets: store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Oral Suspension: Do not store above 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIII
- ATC code
- N03AX22 Perampanel
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 October 2012
- Identifiers
- RxCUI 1356557, 1356563, 1356570 +7DailyMed set ID 71cf3309-e182-473c-8b0b-280cabd0e122, ec812ea3-de3a-4271-957c-db8f692d1ae3NDC 62856-272, 69616-272Application NDA202834
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 69616-272-30 | Catalyst Pharmaceuticals | 2 January 2024 |
| 90 tablet in 1 bottle | 69616-272-90 | Catalyst Pharmaceuticals | 2 January 2024 |
| 30 tablet in 1 bottle | 62856-272-30 | Eisai | 22 October 2012 |
| 90 tablet in 1 bottle | 62856-272-90 | Eisai | 22 October 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Perampanel 2 mg tablet.
Other strengths and forms of Perampanel
Clinical summary
Perampanel is a noncompetitive AMPA glutamate receptor antagonist indicated for treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older, among other approved uses. MedsAcross supplies Perampanel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PerampanelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Fycompa prescribing information (Catalyst Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Fycompa: European public assessment report (EPAR) · European Medicines Agency
Need Fycompa 2 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.